Widespread population immunity from prior infections and updated vaccines, combined with low global SARS-CoV-2 circulation, underpins the 96.2% market-implied probability against a new coronavirus pandemic in 2026. Official WHO surveillance through July 2026 shows test positivity at 3.4% with stable, low activity across regions and no variants under monitoring—primarily XFG and NB.1.8.1 Omicron sublineages—demonstrating increased transmissibility or public health risk. Case counts and deaths remain far below pandemic levels, reflecting endemic equilibrium rather than exponential growth. CDC and WHO assessments classify the overall risk as moderate, with no evidence of immune escape sufficient to drive severe waves. A realistic shift would require an unanticipated variant with substantial new mutations enabling widespread severe disease, though current genomic data and model consensus indicate this remains improbable before year-end.